在多发性硬化症的发病过程中,来自甲基酸的脂质媒介:促进或减缓疾病的进展?
Jelle Y Broos1,2,3, Rianne T M van der Burgt1,2, Julia Konings1,2,4,5
1Department of Molecular Cell Biology and Immunology, Amsterdam UMC, location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Journal of neuroinflammation
|January 17, 2024
概括
来自多重不和脂肪酸的生物活性脂质介质有助于多发性硬化症 (MS) 的病原发生. 调节eicosanoid通路为针对神经炎症和神经退行症的个性化MS治疗提供了潜在的潜力.
科学领域:
- 神经免疫学 神经免疫学
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 多发性硬化症 (MS) 是一种慢性中枢神经系统自身免疫性疾病,患病率越来越高.
- 神经炎症,脱髓和神经退行是MS的关键病理特征.
- 来自多不和脂肪酸 (PUFA) 的生物活性脂质媒介 (LM),与eicosanoids一样,与MS的发病有关,特别是那些来自酸 (AA) 的生物活性脂质媒介.
研究的目的:
- 审查和评估有关eicosanoid通路在MS中的作用的文献.
- 探索特定的eicosanoid生化路径和酶 (COX,LOX) 对MS病理学的贡献.
- 为MS治疗提出针对eicosanoid通路的新型治疗策略.
主要方法:
- 文献综述和对MS中eicosanoids研究的批判性评估.
- 在MS中分析前列腺,白血和HETE通路.
- 讨论MS中LMs的细胞源,细胞和受体配置文件.
主要成果:
- 在MS (PwMS) 患者中报告了LM形状的障碍,特别是AA衍生的LM.
- 由AA衍生的LM与MS中神经炎症和神经退行有关.
- 埃可索诺伊德通路与多发性硬化症的发病有着密切的联系.
结论:
- 在MS的发病过程中,eicosanoid路径起着重要作用.
- 调节eicosanoid通路以实现有益的LM生物合成,可以为MS提供个性化的治疗机会.
- 向eicosanoid通路可能会对抗MS中的慢性神经炎症,脱髓化和神经退行.
相关概念视频
Lipid-derived Compounds in the Human Body
4.4K
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
4.4K
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Inflammation
53.4K
Overview
53.4K
IP3/DAG Signaling Pathway
12.1K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.1K
Antiasthma Drugs: Leukotriene Modifiers
302
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
302


